XML 26 R8.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Cash flows from operating activities:    
Net loss $ (29,727) $ (25,632)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation expense 48 25
Stock-based compensation expense 5,600 45
Non-cash interest expense - related party 121 1,233
Change in fair value of warrant liability (473)  
Changes in operating assets and liabilities, net of impact of assumed net assets of Macrocure:    
Prepaid expenses and other assets (99) (222)
Deferred tax assets (158)  
Research and development incentive receivable 1,458 (3,053)
Accounts payable and accrued expenses 1,093 2,267
Net cash used in operating activities (22,137) (25,337)
Cash flows from investing activities:    
Purchases of property and equipment (64) (144)
Net cash used in investing activities (64) (144)
Cash flows from financing activities:    
Proceeds from issuance of common stock in connection with merger with Macrocure 21,165  
Proceeds from issuance of common stock in connection with Subscription Agreement 10,000  
Proceeds from issuance of common stock in connection with Private Placement 18,000  
Proceeds from notes payable - related party 750 25,900
Proceeds from the exercise of stock options 20  
Payment of offering costs (2,172) (282)
Net cash provided by financing activities 47,763 25,618
Effect of exchange rate changes on cash and cash equivalents (618) 251
Net increase in cash and cash equivalents 24,944 388
Cash and cash equivalents at beginning of period 793 405
Cash and cash equivalents at end of period 25,737 793
Supplemental disclosure of non-cash financing activities:    
Accretion of preferred stock to redemption value (244) (4,650)
Deferred offering costs included in accounts payable and accrued expenses 131 $ 1,120
Conversion of notes payable - related party and accrued interest into common stock 31,145  
Conversion of convertible preferred stock to common stock 70,775  
Value of net assets acquired in connection with merger with Macrocure, excluding cash $ 96